Daskalopoulou D, Harhalakis N, Maouni N, Markidou S G
Cytology Department, Hellenic Anticancer Institute, Saint Savvas Hospital, Athens, Greece.
Acta Cytol. 1995 Mar-Apr;39(2):180-6.
To assess the value of fine needle aspiration cytology (FNAC) in the diagnosis of non-Hodgkin's lymphomas (NHL), we retrospectively studied all the cases diagnosed cytologically as NHL in our laboratory during a five-year period (1987-1991). We also traced cases in which FNAC failed to diagnose NHL and where the diagnosis was made subsequently by histopathology. Fine needle aspiration (FNA) was performed on both peripheral/palpable and deeply situated lesions. A total of 164 specimens were studied cytologically, and for 130 of them a histologic report was available. In 83 of the cases, FNA was carried out as part of the initial evaluation, and in 81 the diagnosis of NHL was known and FNA was performed to confirm or exclude a relapse. In 76 cases for which morphology was inconclusive the immunophenotype was assessed by immunocytochemistry. There were three false-negative and one false-positive result; in none of them was immunophenotyping performed. No discrepancy was observed in the distinction between low and high grade lymphomas, but this was feasible in only 115 of the 164 specimens studied. We conclude that the method is a feasible, rapid and inexpensive first approach in the evaluation of patients with NHL. FNAC may be substituted for histology in the occasional patient for whom the surgical risk outweighs the inaccuracies of the procedure.
为评估细针穿刺细胞学检查(FNAC)在非霍奇金淋巴瘤(NHL)诊断中的价值,我们回顾性研究了本实验室在五年期间(1987 - 1991年)细胞学诊断为NHL的所有病例。我们还追踪了FNAC未能诊断出NHL但随后经组织病理学确诊的病例。对周围/可触及的病变以及深部病变均进行了细针穿刺(FNA)。共对164份标本进行了细胞学研究,其中130份有组织学报告。83例病例中,FNA作为初始评估的一部分进行,81例已知NHL诊断,进行FNA以确认或排除复发。76例形态学结果不明确的病例通过免疫细胞化学评估免疫表型。有3例假阴性和1例假阳性结果;均未进行免疫表型分析。在区分低级别和高级别淋巴瘤方面未观察到差异,但在164份研究标本中只有115份可行。我们得出结论,该方法是评估NHL患者的一种可行、快速且廉价的首选方法。对于手术风险超过该检查不准确性的少数患者,FNAC可替代组织学检查。